Rubella, also known as German measles or three-day measles, is an infectious disease caused by the rubella virus. Here's a comprehensive overview that captures its epidemiology, transmission, affected populations, key statistics, historical context, major risk factors, and impact on different regions and populations.

**Historical Context and Discovery:**
Rubella was first described in the medical literature in the mid-18th century by German physicians. It was initially considered to be a variant of measles or scarlet fever but was later distinguished as a separate disease. The rubella virus was isolated in 1962 by Parkman and Weller. The introduction of the rubella vaccine in 1969 has led to significant decreases in the incidence of the disease in countries with widespread vaccination programs.

**Global Prevalence:**
The global prevalence of rubella has decreased dramatically since the introduction of the rubella vaccine. However, rubella remains a concern in many parts of the world, especially in areas where vaccination coverage is low. The World Health Organization (WHO) has reported significant progress in rubella control, with large regions of the Americas, Europe, and the Western Pacific declaring elimination of endemic rubella transmission. Still, cases occur, and outbreaks can happen, particularly in countries with insufficient immunization coverage.

**Transmission Routes:**
Rubella is highly contagious and is transmitted from person to person through the air via respiratory droplets when an infected person coughs or sneezes. It can also spread through direct contact with an infected person's respiratory secretions. Pregnant women with rubella can transmit the virus to the fetus, which can lead to congenital rubella syndrome (CRS) â€” a severe condition that can cause birth defects or fetal death.

**Affected Populations:**
Rubella can affect individuals of all ages, but it is generally a mild disease in children and adults. Its most significant impact is on pregnant women, especially during the first trimester, when the virus can cause CRS in developing fetuses, leading to severe birth defects such as deafness, blindness, heart defects, and neurological issues. Unvaccinated individuals and those living in regions with poor vaccination coverage are the most susceptible to rubella infection.

**Key Statistics:**
Before the introduction of the rubella vaccine, large outbreaks would occur every 6-9 years, mostly affecting children 5-9 years old. Since vaccination became widespread, reported cases have declined by 99% in many developed countries. Nevertheless, according to WHO, in 2020, there were approximately 120,000 cases of CRS globally, an indicator of the continued presence of the virus in some areas.

**Major Risk Factors Associated with Rubella Transmission:**
- Lack of vaccination or incomplete vaccination coverage.
- Crowded living conditions.
- Travel to areas with endemic rubella transmission or during outbreaks.
- Healthcare environments, where workers may come into contact with infected patients.
- Contact with individuals traveling from regions with low vaccination rates.

**Impact on Different Regions and Populations:**
The impact of rubella varies based on the vaccination policies and healthcare infrastructure of individual regions:
- **Americas**: The Pan American Health Organization (PAHO) announced the elimination of rubella in 2015 due to successful vaccination programs.
- **Europe**: Rubella incidence has dropped with vaccination, but occasional outbreaks occur, particularly in countries where vaccination rates are insufficient.
- **Africa and Southeast Asia**: These regions have higher rates of rubella and CRS due to inconsistent access to vaccination.
- **Western Pacific**: Some countries, such as Australia and Japan, have achieved significant control over rubella, but others are still working toward elimination.

**Variations in Prevalence Rates and Affected Demographics:**
Prevalence rates of rubella are directly related to vaccination policies and coverage. Children and young adults are typically the most affected demographics in regions without routine vaccination. However, where vaccination campaigns have been successful, rubella is less of a public health concern.

In conclusion, while rubella is now rare in many regions due to effective vaccination programs, it still poses a significant risk to pregnant women and their unborn children in areas where vaccine coverage is lacking. The continued global effort to increase vaccination coverage, especially in countries with low immunization rates, remains a critical step in reducing the worldwide prevalence of rubella and preventing CRS.